Patent · US Active

Antibodies against HER3

US9346883B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 11, 2012
Grant dateMay 24, 2016
Priority date
Expiry dateMay 11, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to antibodies against HER3 and their use in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.